Arkansas Children's Hospital Research Institute
Trial Pipeline
A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab
NCT07422337
Effect of Prenatal and Postnatal Intervention Strategies on Breastfeeding Outcomes in Women With Excessive Weight (Ready, Set, Nourish Study)
NCT06929091
We-Move With Windy: Gross Motor Development for Early Childhood
NCT07346300
Ensuring Access to Optimal Therapy in CF: The ENACT Study
NCT07148739
Community Expecting: Exercise During Pregnancy
NCT07343700
The Sweet Dreams Study - Accuracy of Sleep Trackers in Children
NCT06787378
Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement
NCT05875571
The Sweet Kids Study (Stevia on Weight and Energy Effect Over Time)
NCT05992688
Comparison of Uncomplicated Candidemia Therapy Duration in Children
NCT05763251
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
NCT05550298
Protein Requirements for Active Children
NCT04573439
Community Translation of the Expecting Study
NCT04298125
Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care
NCT05287022
Bioenergetic Phenotypes and Cardiometabolic Health
NCT04427462
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
NCT03827694
Glowing and Expecting Follow Up
NCT03108001
vDOT for Newly Diagnosed Pediatric Asthma
NCT05120323
Differences in Nutrient Use During Exercise Between Children of Varying Body Mass Indices and Fitness Levels
NCT04819308
Palmitate Study: A Method Study of Dietary Lipid Oxidation in Toddlers
NCT04408833
Maternal Obesity and Offspring Neurodevelopment
NCT04274140
Implementing a Guidelines-Based M-Health Intervention for High Risk Asthma Patients
NCT03842033
Effects of Maternal Obesity on Offspring Brain Development
NCT03499587
Brain Fuel - Morning Nutrition and Cognitive Function
NCT03386396
Nutrition and Cognitive Function in Preadolescents
NCT02636998
The Expecting Study
NCT02125149
Bone Mineral Content in Healthy Children
NCT01897168
Effects of Maternal Body Composition on Offspring Brain Structure and Function
NCT01822067
Infant Diet Effects on Brain Function and Language Processing (fMRI)
NCT00735423
Nutritional Stimulation of Growth in Children With Short Stature
NCT04226586
Telehealth Enhanced Asthma Management
NCT03414177
Beginnings Study Follow up
NCT03108014
Work of Breathing During Non-invasive Ventilation in Premature Neonates
NCT02788110
A Pilot and Feasibility Study of Mobile-Based Asthma Action Plans
NCT01514760
Improving Outcomes for Hypertensive Children
NCT01485783
Fetal Programming of Obesity
NCT01131117
Energy Expenditure
NCT01068899
Body Composition in Infants and Children
NCT00921817
Immunopathogenesis of Chlamydia
NCT00607659
Bioavailability and Dosing of a Monosaccharide Supplement in Adults
NCT00782392
Ketamine Pharmacokinetics in Children Having Heart Surgery
NCT00598195
Asthma in the Delta Region of Arkansas (ADRA): Prevalence and Morbidity
NCT00589719
Use of Ketamine Prior to Cardiopulmonary Bypass in Children
NCT00556361
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 4 | 2 |
Therapeutic Areas
What the Pipeline for Arkansas Children's Hospital Research Institute Shows
According to the ClinicalTrials.gov registry, Arkansas Children's Hospital Research Institute is linked to 42 US clinical trials across every stage of research activity. Of those, 16 studies are currently recruiting — about 38% of the sponsor's indexed portfolio — and 14 are already marked complete, representing roughly 33% of the total. Recruiting share is one of the more practical signals here: it reflects how much of a sponsor's research is presently open to new participants, while the completed share indicates the depth of finished work that has already contributed registry results. Both counts come directly from the public ClinicalTrials.gov dataset and are refreshed on the registry side; this page mirrors the latest data pull without altering it.
The phase mix for Arkansas Children's Hospital Research Institute reports 2 late-stage studies (Phase 3 and Phase 4 combined) and 1 earlier-phase studies (Phase 1 and Phase 2). A portfolio weighted toward Phase 3 usually reflects an organization advancing candidates toward regulatory review, where the research centers on comparative efficacy and broader safety across larger populations. A heavier Phase 1 and Phase 2 tilt generally indicates exploratory work — safety, dosing, and early signal detection — and is common among research-forward sponsors that seed many early programs. Phase 4 entries, when present, track interventions already in real-world use and typically focus on long-term safety, effectiveness across subgroups, or formulation comparisons.
The top therapeutic focus area indexed for Arkansas Children's Hospital Research Institute is Healthy with 13 linked trials, and 9 other condition areas appear in the top list above. That distribution is a quick read of where the organization concentrates its research attention; it does not imply product availability, market share, or any clinical endorsement. All numbers on this page come from ClinicalTrials.gov maintained by the National Library of Medicine, and counts can shift as new studies are registered or existing ones update their status. This information is provided for reference and educational purposes only, not as medical, investment, or regulatory advice — verify current details directly with ClinicalTrials.gov before relying on any figure here.
Read our methodology — how this data is sourced, computed, and verified.